Among 500 applications, GlakoLens was ranked as one of the top 15 companies in healthcare technologies cohort and was accepted to participate in the T-DEB programme.
The T-DEB programme is funded by Innovate UK‘s Newton Fund. T-DEB is committed to supporting private companies, social enterprises and NGOs in Turkey and the UK to help them take the initial steps towards long-lasting collaborations in innovation, which address the societal challenges impacting underserved communities in Turkey.
As a participant of T-DEB programme, GlakoLens visited the UK in March 2019 to introduce Glakolens’ proprietary technology and develop R&D partnerships.
